CRISPR-Cas9 Gene editing system, non-complex technology; complex patenting
Practices:Patents
Category:Others
Authors | YAMAMOTO, Osamu |
---|---|
Practice Areas | Patents |
Date of publication | Issue 3 2020 |
Publication carrying this article | The Life Sciences Lawyer |
Publisher | CTC Legal Media |
Summary
Mr. Yamamoto analyzes the patents in Japan on CRISPR-Cas9 Gene editing system, including the Intellectual Property High Court decisions on the two patent applications of Broad et al. rendered on February 25, 2020.
Other works by YAMAMOTO, Osamu
-
Articles Intellectual Property、Patents Others
Functionally-claimed antibody patent – the Amgen v Sanofi case
YAMAMOTO, Osamu
-
Books Intellectual Property、Patents Others
Introduction of on-site inspection system in Japan
YAMAMOTO, Osamu
-
Books Intellectual Property、Patents Others
Antibody Patenting: A Practitioner’s Guide to Drafting, Prosecution and Enforcement
YAMAMOTO, Osamu
-
Articles Intellectual Property、Patents Others
Virtual Round Table – Intellectual Property 2018
YAMAMOTO, Osamu
-
Articles Intellectual Property、Patents Others
Digital health in Japan
YAMAMOTO, Osamu
Other works on Patents
-
Books Patents Others
“Assessment of inventive steps when a differentiating feature has multiple technical meanings – positioning of remarkable effects –”
SUEYOSHI, Tsuyoshi
-
Articles Intellectual Property、Patents Others
Functionally-claimed antibody patent – the Amgen v Sanofi case
YAMAMOTO, Osamu
-
Books Intellectual Property、Patents Others
Introduction of on-site inspection system in Japan
YAMAMOTO, Osamu
-
Books Intellectual Property、Patents Others
Antibody Patenting: A Practitioner’s Guide to Drafting, Prosecution and Enforcement
YAMAMOTO, Osamu
-
Articles Patents Laws
Artificial Intelligence (AI) related Patents and the Inspection System under the Revised Japanese Patent Act
OKAMOTO, Yoshinori
Telephone
+81(3)3270-6641